AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF Russian patent published in 2012 - IPC C07C217/64 C07C317/22 C07C323/19 C07C323/32 C07D211/14 C07D295/08 C07D307/79 C07D317/22 C07F9/09 C07F9/655 C07D317/62 C07D333/16 C07D333/28 C07D333/56 C07F9/6553 A61K31/137 A61K31/4453 A61K31/5375 A61K31/661 A61P37/02 A61K31/36 A61P43/00 A61P37/08 A61P41/00 

Abstract RU 2453532 C2

FIELD: chemistry.

SUBSTANCE: invention relates to an amine compound of formula (I), pharmaceutically acceptable addition salts, hydrates or solvates thereof, having immunodepressive effect , where R - H or P(=O)(OH)2; X - O or S; Y denotes -CH2CH2- or -CH=CH-; Z denotes C1-5-alkylene, C2-5-alkenylene or C2-5-alkynylene; R1 denotes CF3, R2 denotes C1-4-alkyl, substituted with OH or halogen; R3 and R4 independently denotes H < or C1-4-alkyl; A denotes optionally substituted C6-10-aryl, heteroaryl containing 5-10 ring atoms, where 1 or 2 atoms are selected from N, O and S, C3-7-cycloalkyl optionally condensed with optionally substituted benzene, or heterocycloalkyl containing 5-7 ring atoms, where 1 or 2 atoms are selected from N and O, where said substitutes are selected from C1-4-alkylthio, C1-4-alkylsulphanyl, C1-4-alkylsulphonyl, C2-5-alkylcarbonyl, halogen, cyano, nitro, C3-7-cycloalkyl, C6-10-aryl, C7-14-aralkyloxy, C6-10-aryloxy, optionally substituted with oxo or halogen, C2-3-alkyleneoxy, C3-4-alkylene or C1-2-alkylenedioxy, optionally substituted with halogen C1-4-alkyl or C1-4-alkoxy.

EFFECT: novel compound which is effective in reducing the level of lymphocytes in peripheral blood, suppresses tissue breakdown and exhibiting less side effects, such as bradycardia, is disclosed.

20 cl, 237 ex, 2 tbl

Similar patents RU2453532C2

Title Year Author Number
AMINE COMPOUND AND ITS APPLICATION IN MEDICINAL PURPOSES 2006
  • Kiuti Masatosi
  • Marukava Kaoru
  • Kobajasi Nobutaka
  • Sugakhara Kunio
RU2433117C2
NEW PHARMACEUTICAL COMPOSITIONS FOR SEXUAL DISORDERS 2005
  • Mendla Klaus
  • Pajk Robert
  • Ajzenrajkh Vol'Fram
  • Fridl' Tomas
RU2445095C2
USING SIP RECEPTOR MODULATOR 2008
  • Barde Iv-Alen
  • Bilbe Grejm
  • Deograsias Ruben
  • Kun Rajner R.
  • Matsumoto Tomoja
  • Mir Anis Khusro
  • Shubart Anna Svenja
RU2498796C2
S1P RECEPTOR MODULATORS FOR MULTIPLE SCLEROSIS TREATMENT 2007
  • Peter S Khishtand
  • Kristian Shnell
RU2617502C2
SIP RECEPTOR MODULATORS FOR TREATING MULTIPLE SCLEROSIS 2007
  • Khishtand Peter S.
  • Shnell' Kristian
RU2495664C2
COMPOSITIONS, BASED ON 2-AMINO-1,3-RPOPANEDIOL COMPOUNDS 2010
  • Tkhitivan Buranachokpaisan
  • Rosa-Mari Dannenfel'Ser
  • Pin Li
RU2468793C2
MODULATORS OF RECEPTOR S1P FOR TREATMENT OF MULTIPLE SCLEROSIS 2007
  • Hiestand Peter C.
  • Schnell Cristian
RU2569732C9
USING SIP RECEPTOR MODULATORS IN OPHTHALMOLOGY 2006
  • Lambru Zhorzh N.
  • Latu Ehlizabet Zhanne
RU2497513C2
AGENTS AGAINST FEEBLE-MINDEDNESS COMPRISING DERIVATIVES OF 2-ARYL-8-OXODIHYDROPURINE AS ACTIVE COMPONENT 2001
  • Furukava Kiesi
  • Kurumija Satosi
  • Khasimoto Takasi
RU2277096C2
DIBENZYLAMINE COMPOUNDS, PHARMACEUTICAL COMPOSITION AND THERAPEUTIC OR PROPHYLACTIC AGENT BASED ON THEREOF, METHOD FOR TREATMENT OR PROPHYLAXIS OF HYPERLIPIDEMIA OR ARTERIOSCLEROSIS 2003
  • Maeda Kimija
  • Nagamori Khironobu
  • Nakamura Khirosi
  • Sinkaj Khisasi
  • Suzuki Jasunori
  • Takakhasi Dajsuke
  • Taniguti Tosio
RU2293078C2

RU 2 453 532 C2

Authors

Kiuti Masatosi

Tasiro Kaoru

Khamada Maiko

Sugakhara Kunio

Dates

2012-06-20Published

2008-06-13Filed